Avi Orr-Urtreger
Genetic Institute
Tel Aviv Sourasky Medical Center
6 Weizmann St
Tel Aviv 64239
Israel
Name/email consistency: high
- Association of Sequence Alterations in the Putative Promoter of RAB7L1 With a Reduced Parkinson Disease Risk. Gan-Or, Z., Bar-Shira, A., Dahary, D., Mirelman, A., Kedmi, M., Gurevich, T., Giladi, N., Orr-Urtreger, A. Arch. Neurol. (2012)
- Decreased expression of B cell related genes in leukocytes of women with Parkinson's disease. Kedmi, M., Bar-Shira, A., Gurevich, T., Giladi, N., Orr-Urtreger, A. Mol. Neurodegener (2011)
- The LRRK2 G2019S mutation in Ashkenazi Jews with Parkinson disease: is there a gender effect? Orr-Urtreger, A., Shifrin, C., Rozovski, U., Rosner, S., Bercovich, D., Gurevich, T., Yagev-More, H., Bar-Shira, A., Giladi, N. Neurology (2007)
- The homozygous P582S mutation in the oxygen-dependent degradation domain of HIF-1 alpha is associated with increased risk for prostate cancer. Orr-Urtreger, A., Bar-Shira, A., Matzkin, H., Mabjeesh, N.J. Prostate (2007)
- RNASEL mutation screening and association study in Ashkenazi and non-Ashkenazi prostate cancer patients. Orr-Urtreger, A., Bar-Shira, A., Bercovich, D., Matarasso, N., Rozovsky, U., Rosner, S., Soloviov, S., Rennert, G., Kadouri, L., Hubert, A., Rennert, H., Matzkin, H. Cancer Epidemiol. Biomarkers Prev. (2006)
